Effect of bupivacaine on intervertebral disc cell viability

Spine Journal

Volumn 10, Issue 2, 2010, Pages 159-166

  Lee, Ho ^a,b   Sowa, Gwendolyn ^a   Vo, Nam ^a   Vadala, Gianluca ^c   O'Connell, Stephen ^a   Studer, Rebecca ^a,d   Kang, James ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Eulji University   (South Korea)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d VAPHS 151 U ^*  (United States)

Author keywords

Apoptosis; Bupivacaine; Cell viability; Intervertebral disc; Local anesthetic; Necrosis

Indexed keywords

ALGINIC ACID; ANTITRYPANOSOMAL AGENT; BUPIVACAINE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANNULUS FIBROSUS; APOPTOSIS; ARTICLE; CARTILAGE CELL; CELL DEATH; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DEGENERATION; INTERVERTEBRAL DISKECTOMY; NONHUMAN; NUCLEUS PULPOSUS; PRIORITY JOURNAL; RABBIT; SPINE;

ANESTHETICS, LOCAL; ANIMALS; BUPIVACAINE; CELL CULTURE TECHNIQUES; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CHONDROCYTES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; INTERVERTEBRAL DISK; RABBITS; TIME FACTORS;

EID: 75149161468     PISSN: 15299430     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spinee.2009.08.445     Document Type: Article

References (26)

1. Cluff R., Mehio A.K., Cohen S.P., et al. The technical aspects of epidural steroid injections: a national survey. Anesth Analg 95 (2002) 403-408
2. Deyo R.A., Mirza S.K., and Martin B.I. Back pain prevalence and visit rates: estimates from U.S. national surveys, 2002. Spine 31 (2006) 2724-2727
3. Boswell M.V., Trescot A.M., Datta S., et al. Interventional techniques: evidence-based practice guidelines in the management of chronic spinal pain. Pain Physician 10 (2007) 7-111
4. Friedly J., Chan L., and Deyo R. Increases in lumbosacral injections in the Medicare population: 1994 to 2001. Spine 32 (2007) 1754-1760
5. Morgan G.E., Mikhail M.S., and Murray MJ. Clinical Anethesiology. 4th ed. (2006), Lange Medical Books/McGraw Hill, New York 263-75
6. Sakura S., Kirihara Y., Muguruma T., et al. The comparative neurotoxicity of intrathecal lidocaine and bupivacaine in rats. Anesth Analg 101 (2005) 541-547
7. Fenton D.S., and Czervionke L.F. Image-guided spine interventioned (2003), Saunders, Philadelphia, PA
8. Slipman C.W., and Chou L.H. Interventional spine: an algorithmic approach (2008), Saunders/Elsevier, Philadelphia, PA
9. Abdel-Salam A., Eyres K.S., and Cleary J. A new paradiscal injection technique for the relief of back spasm after chemonucleolysis. Rheumatology 31 (1992) 491-493
10. Sice P.J., Chan D., and MacIntyre P.A. Epidural analgesia after spinal surgery via intervertebral foramen. Br J Anaesth 94 (2005) 378-380
11. Kotilainen E., Muittari P., and Kirvela O. Intradiscal glycerol or bupivacaine in the treatment of low back pain. Acta Neurochir (Wien) 139 (1997) 541-545
12. Simmons J.W., McMillin J.N., Emery S.F., and Kimmich S.J. Intradiscal steroids. A prospective double-blind clinical trial. Spine 17 (1992) S172-S175
13. Alexandre A., Coro L., Azuelos A., et al. Intradiscal injection of oxygen-ozone gas mixture for the treatment of cervical disc herniations. Acta Neurochir Suppl 92 (2005) 79-82
14. Gallucci M., Limbucci N., Zugaro L., et al. Sciatica: treatment with intradiscal and intraforaminal injections of steroid and oxygen-ozone versus steroid only. Radiology 242 (2007) 907-913
15. Andreula C.F., Simonetti L., De Santis F., et al. Minimally invasive oxygen-ozone therapy for lumbar disk herniation. AJNR Am J Neuroradiol 24 (2003) 996-1000
16. Miller M.R., Mathews R.S., and Reeves K.D. Treatment of painful advanced internal lumbar disc derangement with intradiscal injection of hypertonic dextrose. Pain Physician 9 (2006) 115-121
17. Derby R., Eek B., Lee S.H., et al. Comparison of intradiscal restorative injections and intradiscal electrothermal treatment (IDET) in the treatment of low back pain. Pain Physician 7 (2004) 63-66
18. Chu C.R., Izzo N.J., Papas N.E., and Fu F.H. In vitro exposure to 0.5% bupivacaine is cytotoxic to bovine articular chondrocytes. Arthroscopy 22 (2006) 693-699
19. Dogan N., Erdem A.F., Erman Z., and Kizilkaya M. The effects of bupivacaine and neostigmine on articular cartilage and synovium in the rabbit knee joint. J Int Med Res 32 (2004) 513-519
20. Gomoll A.H., Kang R.W., Williams J.M., et al. Chondrolysis after continuous intra-articular bupivacaine infusion: an experimental model investigating chondrotoxicity in the rabbit shoulder. Arthroscopy 22 (2006) 813-819
21. Zhao C.Q., Wang L.M., Jiang L.S., and Dai L.Y. The cell biology of intervertebral disc aging and degeneration. Ageing Res Rev 6 (2007) 247-261
22. Vallejo R., Benyamin R., Yousuf N., and Kramer J. Intradiscal intravasation of contrast during a transforaminal epidural injection. Pain Pract 7 (2007) 285-287
23. Wallach C.J., Sobajima S., Watanabe Y., et al. Gene transfer of the catabolic inhibitor TIMP-1 increases measured proteoglycans in cells from degenerated human intervertebral discs. Spine 28 (2003) 2331-2337
24. Studer R.K., Aboka A.M., Gilbertson L.G., et al. P38 MAPK inhibition in nucleus pulposus cells: a potential target for treating intervertebral disc degeneration. Spine 32 (2007) 2827-2833
25. Sun X., and Garlid K.D. On the mechanism by which bupivacaine conducts protons across the membranes of mitochondria and liposomes. J Biol Chem 267 (1992) 19147-19154
26. LeMaitre C.L., Freemont A.J., and Hoyland J.A. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 7 (2005) 732-745